Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
OPTN OptiNose
- 5.650
- +0.300+5.61%
Close Feb 26 16:00 ET
56.81MMarket Cap-1.30P/E (TTM)
6.050High5.350Low16.59KVolume5.500Open5.350Pre Close95.35KTurnover0.24%Turnover RatioLossP/E (Static)10.06MShares31.50052wk High-1.38P/B39.11MFloat Cap4.81552wk Low--Dividend TTM6.92MShs Float450.000Historical High--Div YieldTTM13.08%Amplitude4.815Historical Low5.748Avg Price1Lot Size
About OptiNose Company
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
Company Profile
SymbolOPTN
Company NameOptiNose
Listing DateOct 13, 2017
Issue Price16.00
Founded2000
CEODr. Ramy A. Mahmoud, M.D.
MarketNASDAQ
Employees132
Fiscal Year Ends12-31
Address777 Township Line Road,Suite 300
CityYardley
ProvincePennsylvania
CountryUnited States of America
Zip Code19067
Phone1-267-364-3500
Websitehttp://www.optinose.com
Company Executives
- Name
- Position
- Salary
- Dr. Ramy A. Mahmoud, M.D.
- Chief Executive Officer and Director
- 2.41M
- Michael F. Marino, III,
- Chief Legal Officer and Corporate Secretary
- 1.32M
- Paul Spence, Jr
- Chief Commercial Officer
- 664.02K
- Anthony J. Krick
- Vice President, Finance and Chief Accounting Officer
- --
- P. Terence Kohler, Jr
- Chief Financial Officer
- --
- R. John Fletcher
- Chairman of the Board
- 120.22K
- Sandra L. Helton
- Independent Director
- 103.42K
- Wilhelmus C. M. Groenhuysen
- Independent Director
- 100.92K
- Kyle Dempsey
- Independent Director
- 90.92K
- Dr. Eric Bednarski
- Independent Director
- 88.42K
- Tomas J. Heyman
- Independent Director
- 96.88K